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Abstract
Numerous patient-related clinical parameters and treatment-specific variables have been identified as causing or contributing 
to the severity of peritonitis. We postulated that a combination of clinical and surgical markers and scoring systems would 
outperform each of these predictors in isolation. To investigate this hypothesis, we developed a multivariable model to exam-
ine whether survival outcome can reliably be predicted in peritonitis patients treated with open abdomen. This single-center 
retrospective analysis used univariable and multivariable logistic regression modeling in combination with repeated random 
sub-sampling validation to examine the predictive capabilities of domain-specific predictors (i.e., demography, physiology, 
surgery). We analyzed data of 1,351 consecutive adult patients (55.7% male) who underwent open abdominal surgery in 
the study period (January 1998 to December 2018). Core variables included demographics, clinical scores, surgical indices 
and indicators of organ dysfunction, peritonitis index, incision type, fascia closure, wound healing, and fascial dehiscence. 
Postoperative complications were also added when available. A multidomain peritonitis prediction model (MPPM) was con-
structed to bridge the mortality predictions from individual domains (demographic, physiological and surgical). The MPPM 
is based on data of n = 597 patients, features high predictive capabilities (area under the receiver operating curve: 0.87 (0.85 
to 0.90, 95% CI)) and is well calibrated. The surgical predictor “skin closure” was found to be the most important predic-
tor of survival in our cohort, closely followed by the two physiological predictors SAPS-II and MPI. Marginal effects plots 
highlight the effect of individual outcomes on the prediction of survival outcome in patients undergoing staged laparotomies 
for treatment of peritonitis. Although most single indices exhibited moderate performance, we observed that the predictive 
performance was markedly increased when an integrative prediction model was applied. Our proposed MPPM integrative 
prediction model may outperform the predictive power of current models.
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1 Introduction
Primary and secondary infectious peritonitis pose major 
challenges for clinicians globally [1, 2] . Despite extensive 
research and aggressive surgical management of source 
control–such as open abdominal clinical strategies with 
repeated abdominal lavage or interventions–the progno-
sis of generalized peritonitis remains poor, with mortality 
rates of up to 60% [3] . There is some evidence of favorable 
outcomes when using staged relaparotomies and repeated 
lavage in selected cohorts [1, 4, 5] . This approach is now 
accepted as a standard procedure for the septic abdomen 
[6, 7].
Patients usually undergo explorative laparotomy if peri-
tonitis is suspected. Following meticulous exploration of 
the abdomen, thorough cleansing with copious fluids, and 
surgical repair of lesions, the abdominal cavity is left open 
and the small bowel is protected with an intestine bag. To 
minimize abdominal wall retraction during open abdomen 
treatment, a mesh is sutured into the dorsal aspect of the 
rectus muscle.
Despite considerable clinical and scientific efforts, mor-
tality remains high in these patients, and predictive scores 
are warranted to change the clinical approach from “reac-
tion to deterioration” towards a more proactive “anticipation 
of deterioration”. [8] Bosscha et al. previously stated that 
 * Markus M. Luedi 
 markus.luedi2@insel.ch
Extended author information available on the last page of the article
 Journal of Clinical Monitoring and Computing
1 3
early and reliable classification of intra-abdominal sepsis is 
essential. This could further be useful to select patients for 
aggressive surgical techniques and to evaluate and compare 
the results of different clinical treatment regimens [9] . Boss-
cha et al. demonstrated an association of the Mannheim Peri-
tonitis Index (MPI) and the Acute Physiology And Chronic 
Health Evaluation (APACHE) II in a cohort of peritonitis 
patients [9] . In light of the study design and the focus on 
chronic concomitant diseases, the best resource allocation 
and acute surgical management in these patients remains 
controversial [10] . Another group assessed the feasibility 
of predicting mortality with a country-specific calibrated 
Simplified Acute Physiology Score (SAPS) II in intensive 
care (ICU) patients, and showed that overall mortality is 
overestimated when the SAPS II is used [11] . We hypoth-
esized that an integrative approach may be useful to improve 
prediction modeling in patients with peritonitis, and could 
include demographics, typical physiological scoring systems 
(SAPS II and MPI) as well as a specific clinical course.
The need for advanced prediction models might lead us to 
a better understanding of the variables that affect this clinical 
challenge. Therefore, we investigated the utility of a newly 
designed multivariable approach that deliberately employs 
laborartory results and clinical and surgical indices. This 
was done in an effort to best reflect the clinical challenges 
facing a large cohort of peritonitis patients undergoing open 
abdomen and staged lavage treatment. We combined typi-
cal clinical scores with surgical parameters, as this might 
best reflect the decision-making performed by health care 
professionals.
2  Methods
The study was performed in adherence to the principles in 
the Declaration of Helsinki, and approved by the Hamburg 
Medical Association (#WF072/20) as the responsible insti-
tutional review board/human ethics board. The need for 
individual patients’ or legal surrogates’ or parents’ or legal 
guardians’ written informed consent was deemed unneces-
sary, given the retrospective nature of the data analysis.
2.1  Patients
Data of 1,351 adult patients treated for peritonitis in the 
Department of General and Visceral Surgery of the Askle-
pios Hospital Altona, Hamburg, Germany, were analyzed 
retrospectively. All adult patients were treated in the unit 
ICU and had undergone open abdomen treatment and staged 
lavage during the study interval (January 1998 to Decem-
ber 2018). For “transparent reporting of a multivariable 
prediction model for individual prognosis or diagnosis” we 
followed the Equator TRIPOD statement [12].
2.2  Measurements
Age at admission, Mannheim Peritonitis Index (MPI), 
number of staged lavages, duration of mechanical venti-
lation (in hours), incision type (median vs. transverse) dur-
ing staged lavage, fascia closure at the end of the staged 
lavage, presence of a wound-healing disorder, fascial 
dehiscence, postoperative complications, and mortality 
were documented.
SAPS-II scores [13–15] were available for the period 
1998 to 2018 and MPI scores from 2008 to 2018. SAPS-II 
scores were lower during the years 1998 to 2007 (median 
40.0 and interquartile range [32.0–52.0]) than during the 
period 2008–2018 (46.0 [36.0–57.0]), for  which both 
physiological scores were available (p < 0.001). This pos-
sible source of bias in our analysis of mortality prediction 
is discussed within the context of the limitations of this 
study. A full data availability atable is presented in the 
Supplementary Material.
The following standard surgical procedures applied: 
type of incision was based on the incision previously 
performed. When no previous abdominal incisions or 
laparoscopic trocar incisions were recorded or observed, 
a transverse incision was used. All four quadrants were 
inspected and thoroughly cleaned with copious fluid. After 
ensuring that no infectious pockets were left undrained, 
the abdominal cavity was left open, the small bowel was 
covered with negative pressure (Vi-Drape® intestine bag, 
Cardinal Health GmbH, 22,848 Norderstedt, Germany), 
and Parietex® mesh (Medtronic GmbH, 40,670 Meer-
busch, Germany) was sutured into the dorsal aspect of the 
rectus muscle.
Wound-healing disorders (WHD) were defined as any 
evidence of cutaneous wound infection or need for reo-
pening of a skin wound, with or without bacteria detected 
in microbiological swabs. Any evidence of reopening of 
the fascia after the closure of staged lavage was defined 
as fascial dehiscence. Data on the severity of the disease, 
as determined by the SAPS-II score, were collected upon 
admission to the intensive care unit. The surgical results 
were determined retrospectively.
2.3  Statistical analyses
Continuous variables were expressed as mean and standard 
deviation when normally distributed, based on a Shap-
iro–Wilk test of normality and visual inspection of Q-Q 
plots, and as median and interquartile range (IQR) other-
wise [16] . Differences in a continuous outcome between 
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two groups were assessed with Student’s T-test in case of 
normally distributed outcomes and with a Mann–Whitney 
Test otherwise. Proportions are presented as numbers and 
percentages, and tests of association of two groups with 
a binary outcome were performed using a chi-square test.
To assess the ability of the various demographic, physi-
ological and surgical variables to predict the binary survival 
outcome, we first computed univariable logistic regression 
for each predictor. Second, those predictors associated with 
the mortality outcome and with sufficient observations were 
selected and combined in domain-specific multivariable 
logistic regression models (demographics, physiological, 
surgical) to examine the individual prediction skill of each 
domain. Finally, all predictors were combined in a multi-
variable logistic regression model [17] . Goodness of fit of 
these models was assessed with the Hosmer–Lemeshow 
test as well as with calibration plots, and overall model per-
formance was quantified using the Brier Score [18, 19] . 
The discriminative ability of each logistic regression model 
was computed with concordance statistics/the area under 
the receiver operating curve (AUROC) [20, 21] . Predic-
tor importance in the multi-domain prediction model was 
assessed with two methods: (i) the absolute value of the 
t-statistic for each model parameter and (ii) dominance 
analysis [22, 23] . In terms of missing data, we followed a 
complete case analysis and omitted missing values for each 
regression model.
In order to (i) internally validate the models’ ability to 
discriminate between the survival outcome (as expressed 
with the AUROC values for each regression model) and (ii) 
to compare the predictive skill across single predictor mod-
els, domain-specific models and the multidomain model, we 
employed a repeated random sub-sampling validation for 
each regression model. The following steps were repeated 
a thousand times for each regression model: (1) The avail-
able data was randomly divided into a training set (contain-
ing 65% of the available data) and the logistic regression 
model was fit using this training data. (2) To categorize the 
model prediction probabilities into the binary survival out-
come categories (survived, died), an optimal cutoff value for 
the predicted probabilities was computed according to the 
Youden Index. (3) The fitted regression model—in combina-
tion with the optimal cutoff value—was subsequently used to 
predict the individual binary outcomes of the validation set 
(containing the remaining 35% of the data). (4) The follow-
ing indicators of prediction performance were computed for 
the validation set: balanced accuracy, sensitivity, specificity, 
positive predictive value, negative predictive value and the 
diagnostic odds ratio [24] . Overall, this validation proce-
dure resulted in a distribution with 1,000 samples for the 
indicators of prediction performance which were depicted 
with box plots.
To determine the sample size required for the logistic 
regression models, we followed the method of Peduzzi 
et al. 1996: [25] assuming 10 possible covariates in the full 
multi-domain regression model and a mortality rate of 20%, 
we calculated 500 as the minimum number of patients. A 
p < 0.05 was considered statistically significant. All statis-
tical analyses were computed with R (R version 4.0.2; R 
Core Team 2020). Calibration plots were computed with the 
package givitiR [26].
3  Results
3.1  Demographics and clinical outcome
Data of 1,351 consecutive patients undergoing staged lapa-
rotomies were analyzed. Table 1 describes the patients’ 
demographic, physiological and surgery-related vari-
ables and compares the variable distribution in surviving 
and deceased patients. In-hospital survivors were younger 
(median 64.0 years and interquartile range [52.0–73.0] years 
than non-survivors (73.0 [63.0–78.0] years, p < 0.001). 
They had lower SAPS-II scores (40.0 [33.0–50.0] versus 
56.0 [45.0–66.0], p < 0.001) and lower MPI scores (19.0 
[12.2–26.0] versus 26.0 [16.0–32.2], p < 0.001). And they 
required less time on mechanical ventilation (140 [63.0–352] 
hours versus 306 [74.0–538] hours, p < 0.001). In terms of 
surgical procedures, fascial and skin closure and evidence 
of wound healing disorder were associated with clinical out-
come (p < 0.001).
3.2  Domain‑specific prediction models
We next considered the association between individuals’ 
demographic, physiological and surgical variables and the 
binary survival outcome (Table 2). Here, univariable logistic 
regression reveals significant associations between mortal-
ity and patient age, SAPS-II and MPI scores, the number 
of days in the ICU, as well as for wound complications and 
surgical management (skin and fascial closure). The area 
under the curve (AUROC) is shown as a measure of the 
predictive value of the univariable model. Here the SAPS-
II regression model provides the highest AUROC value of 
0.75 (0.72–0.79, 95% CI) relative to the other variables, with 
AUROC values in the range of 0.51 (0.47–0.55) (BMI) to 
0.66 (0.63–0.70) (Age).
To examine the predictive capabilities of the demo-
graphic, physiological and surgical domain, we grouped 
the predictors into domain-specific multivariable logistic 
regression models (Table 3). Calibration plots for these three 
models of predicted mortality versus observed mortality in 
our cohort are shown in Fig. 1. The demographic prediction 
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model is well calibrated, whereas the physiological predic-
tion underestimates the mortality for low probabilities on 
the one hand and overestimates high mortality probabilities 
on the other hand. The surgical prediction model generally 
overestimates the observed mortality in the cohort.
We found that patient age was the strongest predictor 
of the demographic variables, with an odds ratio (OR) of 
1.04 (1.02–1.06, 95% CI). A unit increase in the SAPS-II 
score and MPI score increases the odds of mortality by 
6% (5%–8%) and 5% (3%–7%), respectively. The odds 
Table 1  Demographic, physiological and surgery-related variables in the cohort of patients undergoing staged laparotomies for peritonitis
All patients (N = 1351) Survived (N = 1082) Died (N = 269) P
Demographics
Sex (male) 750 (55.7%) 587 (54.4%) 163 (60.8%) 0.068
Age (years) 66.0 (54.0–75.0) 64.0 (52.0–73.0) 73.0 (63.0–78.0)  < 0.001
Height (cm) 170 (163–178) 170 (163–178) 170 (160–176) 0.258
Weight (kg) 75.0 (65.0–85.2) 75.0 (65.0–85.5) 76.0 (64.0–85.0) 0.835
BMI (kg/m2) 25.1 (22.6–28.7) 25.1 (22.7–28.4) 25.5 (22.5–29.3) 0.694
Physiology
SAPS-II Score 43.0 (34.0–54.0) 40.0 (33.0–50.0) 56.0 (45.0–66.0)  < 0.001
Mannheimer Peritonitis Index (MPI) 21.0 (14.0–28.0) 19.0 (12.2–26.0) 26.0 (16.0–32.2)  < 0.001
Number of lavages 0.727
1 709 (52.5%) 576 (53.2%) 133 (49.4%)
2 270 (20.0%) 209 (19.3%) 61 (22.7%)
3 142 (10.5%) 111 (10.3%) 31 (11.5%)
4 85 (6.29%) 71 (6.56%) 14 (5.20%)
5 38 (2.81%) 30 (2.77%) 8 (2.97%)
 > 5 107 (7.92%) 85 (7.86%) 22 (8.18%)
Days in ICU 10.0 (4.00–21.0) 9.00 (4.00–20.0) 13.0 (3.00–24.0) 0.019
Hours of ventilation 157 (64.0–402) 140 (63.0–352) 306 (74.0–538)  < 0.001
Hours of hemofiltration 154 (63.5–306) 164 (96.2–296) 133 (30.0–316) 0.057
Surgery
Index operation 0.768
Median laparotomy 146 (24.7%) 104 (23.9%) 42 (26.8%)
Transverse laparotomy 374 (63.2%) 277 (63.7%) 97 (61.8%)
Others 72 (12.2%) 54 (12.4%) 18 (11.5%)
Open abdomen treatment 0.906
Median 158 (26.8%) 117 (27.0%) 41 (26.5%)
Transverse 416 (70.6%) 305 (70.3%) 111 (71.6%)
Others 15 (2.55%) 12 (2.76%) 3 (1.94%)
Fascia closure  < 0.001
No 55 (9.20%) 4 (0.91%) 51 (31.9%)
Yes 543 (90.8%) 434 (99.1%) 109 (68.1%)
Skin closure  < 0.001
No 57 (9.53%) 6 (1.37%) 51 (31.9%)
Yes 541 (90.5%) 432 (98.6%) 109 (68.1%)
Wound healing disorder 0.002
No 455 (76.0%) 318 (72.6%) 137 (85.1%)
Yes 144 (24.0%) 120 (27.4%) 24 (14.9%)
Fascia complication 0.861
No 558 (93.2%) 409 (93.4%) 149 (92.5%)
Yes 41 (6.84%) 29 (6.62%) 12 (7.45%)
Vacuum treatment 0.374
No 553 (92.5%) 402 (91.8%) 151 (94.4%)
Yes 45 (7.53%) 36 (8.22%) 9 (5.62%)
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of survival strongly increase in cases of successful skin 
closure, with an odds ratio of 0.03 (0.01–0.06). In the 
context of mortality prediction, the demographic model 
shows a moderate AUROC value of 0.67 (0.63–0.70), 
with a similar AUROC of 0.69 (0.65–0.74) for the 
surgical predictors. The physiological prediction model 
shows the highest AUROC of 0.77 (0.73–0.82) of the 
domain-specific prediction models.
3.3  The integrative prediction models
A final prediction model—the multidomain peritonitis 
prediction model (MPPM)—was constructed (Table 4). 
The model is built upon the clinical observation that an 
integrative data analysis might best indicate clinical out-
comes. The MPPM is based on data of n = 597 patients, 
features a high AUROC value of 0.87 (0.85–0.90) and a 
Brier Score of 0.12, and is well calibrated (Fig. 1D). Fig-
ure 2 illustrates the marginal effects for each predictor, 
and highlights that mortality steadily increases for older 
patients and higher SAPS-II and MPI scores. For example, 
a SAPS-II score of 80 predicts a survival probability of 
56% (41%–70%, 95% CI), holding the other predictors at 
the values referenced in Fig. 2 constant. Skin closure at 
the end of surgery is a powerful predictor of survival: in 
patients in whom skin closure cannot be achieved, mor-
tality is predicted to be 90% (78%–96%) when the other 
predictors are held constant.
Supplemental Fig. 2 illustrates the relative importance of 
the individual predictors in the integrative MPPM model. 
Estimates of the relative importance based on the absolute 
value of the t-statistic in the prediction model are shown 
in Panel A, whereas dominance analysis was employed to 
compute the estimates of relative importance in Panel B. The 
latter method systematically examines all possible subsets of 
Table 2  Univariable logistic 
regression models for the binary 
survival outcome
OR  odds ratio, CI  confidence interval, OAT open abdomen treatment, WHD wound healing disorders
OR 95% CI P AUROC Brier Hoslem McFadden
Age 1.04 1.03,1.05  < 0.001 0.66 (0.63–0.69) 0.15 0.983 0.05
Sex [Male] 1.30 0.99,1.71 0.059 0.53 (0.50–0.56) 0.16 1.000 0.00
BMI 1.00 0.98,1.03 0.72 0.51 (0.46–0.55) 0.16 0.680 0.00
SAPS-II 1.06 1.05,1.07  < 0.001 0.75 (0.72–0.79) 0.14 0.058 0.14
MPI 1.06 1.04,1.08  < 0.001 0.65 (0.60–0.70) 0.18 0.015 0.05
Days in ICU 1.01 1.00,1.01 0.019 0.55 (0.51–0.59) 0.16 0.000 0.00
Hemofiltration [Yes] 8.72 6.22,12.29  < 0.001 0.66 (0.63–0.69) 0.14 1.000 0.12
WHD [Yes] 0.46 0.28,0.74 0.002 0.56 (0.53–0.60) 0.19 1.000 0.02
Index Operation 0.52 (0.47–0.56) 0.19 1.000 0.00
Median ref
Transverse 0.87 0.57,1.34 0.512
Others 0.83 0.43,1.55 0.558
OAT 0.51 (0.47–0.55) 0.19 1.000 0.00
Median Ref
Transverse 1.04 0.69,1.59 0.859
Others 0.71 0.16,2.38 0.615
Fascia closure [Yes] 0.02 0.01,0.05  < 0.001 0.65 (0.62–0.69) 0.15 1.000 0.17
Skin Closure [Yes] 0.03 0.01,0.07  < 0.001 0.65 (0.62–0.69) 0.15 1.000 0.16
Table 3  Domain-specific multivariable logistic regression model for 
the binary survival “outcome”
OR odds ratio, CI confidence interval
a N = 1347, Brier-Score 0.15, AUROC 0.67 (0.63–0.7), Hosmer–
Lemeshow Goodness of Fit Test 0.99
b N = 598, Brier-Score 0.16, AUROC 0.77 (0.73–0.82), Hosmer–
Lemeshow Goodness of Fit Test 0.76
c N = 598, Brier-Score 0.15, AUROC 0.69 (0.65–0.74), Hosmer–
Lemeshow Goodness of Fit Test 1.00
OR 95% CI p-value
Demographic prediction modela
Age 1.04 1.03, 1.06  < 0.001
Sex [male] 1.45 1.09, 1.92 0.010
Physiological prediction modelb
SAPS-II Score 1.06 1.05, 1.08  < 0.001
MPI Score 1.05 1.03, 1.07  < 0.001
Days in ICU 0.99 0.98, 1.01 0.3
Surgical prediction modelc
Wound healing disorders [Yes] 0.38 0.21, 0.65  < 0.001
Skin closure [Yes] 0.03 0.01, 0.06  < 0.001
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the model predictors and evaluates the additional contribu-
tion of a particular predictor to a measure of model fit (in our 
case McFadden’s  R2). The two independent methods agree 
in their overall ranking of variable importance.
The physiological predictors SAPS-II score and MPI 
score are slightly less important than skin closure.
The demographic predictors appear to be only margin-
ally important relative to the surgical and physiological 
predictors.
3.4  Comparison of domain‑specific and integrative 
prediction models
To conclude, we compared the predictive ability of the sin-
gle predictor models and the three domain-specific mod-
els (demographic, physiological, surgical) with the inte-
grative multidomain peritonitis prediction model within 
a repeated random sub-sampling validation framework. 
Figure 3 shows the median and interquartile ranges for a 
suite of performance indicators in the 1,000 random sub-
sampling ensemble. Note that the regression coefficients 
used for the mortality prediction probabilities and the opti-
mal cutoff for distinguishing between survival and death 
Fig. 1  Calibration plots of predicted mortality versus observed mor-
tality. Calibration plots of predicted mortality versus observed mor-
tality using demographic predictors (age and sex of the patients; 
panel A), physiological predictors (SAPS-II and MPI scores; panel 
B), surgical predictors (wound healing disorders and skin closure; 
panel C). Panel D illustrates the calibration of the multidomain peri-
tonitis prediction model, which includes the predictors from all three 
domains. The diagonal red lines denote a 1:1 relationship between 
predicted and observed mortality
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were solely based on the data of random training sets. 
The MPPM model features the overall highest balanced 
accuracy, with a median of 78% (76%–80%, interquartile 
range). The surgical-domain model demonstrates a higher 
diagnostic odds ratio (median 34; IQR: 24–62) than the 
multidomain model (median 13; IQR: 10–16). It is charac-
terized by a low proportion of correctly identified positives 
(sensitivity) but a high proportion of correctly identified 
negatives (specificity).
While individual domain-specific models show capabili-
ties similar to those of the MPPM for some indicators, such 
as the physiological model for sensitivity, Fig. 3 illustrates 
the key finding of our study—that combining the predictors 
of various domains increases the overall ability to predict 
Table 4  The final multivariable logistic regression models for the 
binary survival outcome (multidomain peritonitis prediction model)
OR  odds ratio, CI confidence interval
a N = 597, Brier-Score 0.12, AUROC 0.87 (0.85–0.90), Hosmer–
Lemeshow Goodness of Fit Test 0.605
Multidomain peritonitis prediction 
 modela
OR 95% CI p-value
Age 1.04 1.02, 1.06  < 0.001
Sex [male] 1.19 0.74, 1.95 0.47
SAPS-II Score 1.05 1.04, 1.07  < 0.001
MPI Score 1.06 1.03, 1.08  < 0.001
Days in ICU 1.00 0.98, 1.01 0.8
Wound healing disorders (WHD) [Yes] 0.29 0.15, 0.54  < 0.001
Skin closure [Yes] 0.02 0.01, 0.06  < 0.001
Fig. 2  Marginal effects plots of the multidomain peritonitis predic-
tion model. Shaded bands and error bars denote the 95% confidence 
interval. A, B demographic predictors, C-E physiological predictors 
and F-G surgical predictors. Only one predictor is varied in each 
panel while the other predictors are held constant: here, the predictor-
specific predictions are adjusted for a 66 year old male patient with 
SAPS-II and MPI scores of 46 and 21, respectively, 21 days at ICU 
with no wound healing disorders and successful skin closure. Note 
that changing these adjustment values would result only in a vertical 
shift the outcome predictions – the shape of the curves as well as the 
prediction differences between categories would remain the same
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Fig. 3  Diagnostic performance of single predictor models, domain-
specific models and the multidomain peritonitis prediction model in 
predicting the survival outcome in patients with open abdomen treat-
ment for peritonitis. A repeated random sub-sampling validation was 
used to compute distributions of quantitative indicators (balanced 
accuracy, log diagnostic odds ratio, negative predictive value, positive 
predictive value, sensitivity and specificity). Box plots illustrate the 
median and interquartile ranges of these distribution. Capitalized pre-
dictors denote logistic regression models including all predictors of 
a particular domain, i.e., the model DEMOGRAPHICS includes the 
age of the patient and sex as predictors
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the binary survival outcome in patients undergoing staged 
laparotomies for peritonitis treatment (see Fig. 1).
4  Discussion
Prediction modeling seems of great clinical importance in 
the clinical scenario investigated. Current predictions mostly 
rely on single-index analyses. We demonstrate that integra-
tive modeling using available information about demograph-
ics, disease severity, physiological parameters, and medical 
interventions can outperform previous prediction models, 
highlighting the importance of our integrative (MPPM model) 
approach.
Concerning peritonitis treatment, there has been ongoing 
discussion for years as to whether open abdomen treatment 
is justified, or whether a so-called “second look on demand” 
makes more sense. Although this is not the main focus of this 
analysis, the data presented here show a relatively low mor-
tality rate compared to publications showing the results of 
second-look on-demand patients [5, 31, 32] . Cocollini from 
the “International Register of open abdomen” concluded that 
temporary abdominal closure remains reliable and safe as a 
treatment for severely injured and acute care surgery patients 
[33]. For peritonitis, the second major endpoint in case of 
an open abdomen is closure at the end of open treatment. In 
recent years, multiple working groups have put considerable 
effort into evaluating vacuum-assisted therapy as a treatment 
option for peritonitis in order to improve the closure rate 
[34, 35] . The benefits of vacuum-assisted therapy are that 
the effort needed for repeated lavage treatments is minimized 
and the rate of patients with successful abdominal wall clo-
sure is higher. In our analysis the observed closure rate using 
open abdomen treatment was 87%, which is relatively high 
compared to studies using vacuum-assisted options [36–38] 
. Either therapy is futile, though, if the predicted outcome is 
bleak.
Outcome prediction is typically performed using single 
clinical and surgical markers and isolated scoring systems 
such as the SAPS II score. We showed that a combination 
of those dimensions outperforms predictions based on single 
indices. This was possible because the data analysis was based 
on a large single-center group of patients with peritonitis. The 
patients’ individual factors were collected prospectively for the 
SAPS-II score, with further treatment-specific factors being 
added in a retrospective analysis.
The major advantage of this data analysis is its consistent 
cohort, with open abdomen treatment being performed uni-
formly over two decades. Intensive care strategies have also 
remained unchanged. As demonstrated in Fig. 1, there are only 
minor changes in the SAPS-II scoring evaluated over 20 years.
4.1  Limitations
Our work has several important limitations that deserve 
discussion. First, data were assessed retrospectively, with 
all inherent limitations driven by study design. While data 
were consistently documented in a timely manner following 
OR procedures, recall bias could theoretically apply. Impor-
tantly, the MPI was calculated from findings during surgery 
[27] . While this scoring system leaves room for interpreta-
tion and is logically limited in terms of power, the MPI was 
shown to be an accepted tool for mortality prediction [28] . 
It should be emphasized that only in-hospital mortality was 
analyzed.
Second, regardless of the power of our proposed pre-
diction model, no single clinical scoring system should 
be a substitute for clinical decision-making. Nevertheless, 
although we regard it as a strength of our model that a multi-
variable approach deliberately includes important clinical 
variables, clinical decision-making should not solely be 
based on even such sophisticated models.
Using the SAPS-II score, the majority of vital signs—
including oxygenation, renal function and results from blood 
samples—were included at the time of admission to the ICU 
[15] . In addition, the data availability changed in the mid-
dle of the observation period, when additional physiological 
(MPI score) and surgical predictors (i.e., wound-healing dis-
order) became available. We thus note that the comparison 
of univariable prediction models as well as the comparison 
of domain-specific models (for example, the physiological 
prediction model versus the surgical prediction model) are 
not based on the same patients but rather on different sub-
samples of the entire cohort.
5  Conclusion
Currently, prediction modeling mainly relies on single-index 
(or combination-index) analyses. With the multidomain peri-
tonitis prediction model we demonstrate that integrative 
modeling using available information such as demograph-
ics, disease severity, physiological parameters, and medical 
interventions outperforms previous models. In the case of 
a severely compromised patient with peritonitis, our model 
suggests that the predictive power is best when all predictive 
parameters from the performance status are combined. This 
could lead to more reliable outcome prediction, and reflects 
the great importance of the interdisciplinary combination 
of surgical, laboratory, and clinical expertise, leading to 
improved decision-making in experienced physicians.
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